Expressions of junB and c-fos are enhanced in 4-nitroquinoline 1-oxide-induced rat tongue cancers

被引:11
作者
Ohyama, M
Hirayama, Y
Tanuma, J
Hirano, M
Semba, I
Shisa, H
Hiai, H
Sugihara, K
Kitano, M
机构
[1] Kagoshima Univ, Sch Dent, Dept Oral Pathol, Kagoshima 8908544, Japan
[2] Kagoshima Univ, Sch Dent, Dept Oral & Maxillofacial Surg 1, Kagoshima 8908544, Japan
[3] Saitama Canc Ctr, Res Inst, Lab Basic Canc Study, Saitama, Japan
[4] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto, Japan
关键词
4-nitroquinoline 1-oxide (4NQO); c-fos; junB; rat tongue cancer; Tscc1;
D O I
10.1046/j.1440-1827.2003.01587.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Activator protein-1 (AP-1) is a transcription factor activated in many tumors. Using 4-nitroquinoline 1-oxide (4NQO)-induced rat tongue cancers (TC), the present study investigated the expression levels of genes that encode the components of AP-1, the jun gene family (c-jun, junB and junD) and the fos gene family (c-fos, fra-1, fra-2 and fosB). Expression levels of junB and c-fos mRNAs in TC were significantly elevated compared with those in epithelial tissue of control rat tongue, although only c-fos mRNA levels tended to be elevated in dysplastic tongue epithelium. Histologically, all 4NQO-induced rat TC were well-differentiated squamous cell carcinomas. Immunostaining for JunB and c-Fos proteins was positive in the nuclei of tumor cells of all TC. It is noteworthy that JunB was negative, but c-Fos was positive in the dysplastic tongue epithelium of the 4NQO-treated rats. Immunostaining for both proteins was negative in tongue mucosal epithelium of control rats. There were no mutations in the coding regions of either junB or c-fos in all the TC examined. These results suggest the possibility that the expressions of junB and c-fos were enhanced stepwise in 4NQO-induced carcinogenesis of rat tongue, and that the coexpression of JunB and c-Fos might play an important role in the establishment of TC.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 34 条
  • [1] Cell cycle promoting activity of JunB through cyclin A activation
    Andrecht, S
    Kolbus, A
    Hartenstein, B
    Angel, P
    Schorpp-Kistner, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (39) : 35961 - 35968
  • [2] Expression pattern of the AP-1 family in endometrial cancer:: correlations with cell cycle regulators
    Bamberger, AM
    Milde-Langosch, K
    Rössing, E
    Goemann, C
    Löning, T
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (09) : 545 - 550
  • [3] ABERRANT SUBCELLULAR-LOCALIZATION OF BRCA1 IN BREAST-CANCER
    CHEN, YM
    CHEN, CF
    RILEY, DJ
    ALLRED, DC
    CHEN, PL
    VONHOFF, D
    OSBORNE, CK
    LEE, WH
    [J]. SCIENCE, 1995, 270 (5237) : 789 - 791
  • [4] JUN-B DIFFERS IN ITS BIOLOGICAL PROPERTIES FROM, AND IS A NEGATIVE REGULATOR OF, C-JUN
    CHIU, R
    ANGEL, P
    KARIN, M
    [J]. CELL, 1989, 59 (06) : 979 - 986
  • [5] Ding W, 2001, J CELL SCI, V114, P1011
  • [6] Expression profiles of JunB and c-Fos proteins in the rat circadian system
    Edelstein, K
    Beaulé, C
    D'Abramo, R
    Amir, S
    [J]. BRAIN RESEARCH, 2000, 870 (1-2) : 54 - 65
  • [7] JunB negatively regulates AP-1 activity and cell proliferation of malignant mouse keratinocytes
    Finch, JS
    Joseloff, E
    Bowden, GT
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (01) : 3 - 10
  • [8] GREENHALGH DA, 1993, CANCER RES, V53, P5071
  • [9] HOLLANDER MC, 1989, CANCER RES, V49, P1687
  • [10] Loss of JunB activity enhances stromelysin I expression in a model of the epithelial-to-mesenchymal transition of mouse skin tumors
    Hulboy, DL
    Matrisian, LM
    Crawford, HC
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (16) : 5478 - 5487